MAS1L and chronic kidney disease: However, the expression of renin, a key enzyme of the RAAS pathway which plays an adverse role in hypertension and CKD [42,43], and the expression of MasR, have no statistical change between the WT and αMUPA mice following AKI (Figure 7B,C).